ASE & BIO
2Patents
2Active
2Granted
40Portfolio score
Filing activity: May 3, 2007 → Dec 20, 2007 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8367641B2 | Use of modified oligo-β-(1,3)-glucans for treating diseases of the immune system, oligo-β-(1,3)-glucan-(1,3)-mannose, oligo-β-(1,3)-glucan-(1,3)-mannitol and derivatives thereof, methods for preparing them and medicaments containing them | Emerging Cross-Sectional Technologies | 0 | Active |
| US8288363B2 | Medicaments for anti-herpes virus treatments | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.